Back to Search
DELLA MAKOWER, MD
MD
Hematology & Oncology Physician
NPI: 1578559910Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
183713(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1990
Research & Publications (9)
A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma.
PMID 12743982·Cancer Invest·2003
3-trial
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).
PMID 15356646·Leukemia·2004
3-trial
Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion.
PMID 15117978·J Clin Oncol·2004
3-trial
Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.
PMID 12538449·Clin Cancer Res·2003
8-other
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.
PMID 12576437·Clin Cancer Res·2003
3-trial
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies.
PMID 12393999·Am J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 LONGVIEW AVE., STE. 201
WHITE PLAINS, NY 10601 - Phone
- (914) 684-2779
Quick Facts
- NPI
- 1578559910
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 9
Are you this provider?
Claim Your Profile